Page 67 - Read Online

Page 14 of 14 Kleerebezem et al. Microbiome Res Rep 2024;3:46 https://dx.doi.org/10.20517/mrr.2024.48

195-203. DOI
54. Lordan C, Thapa D, Ross RP, Cotter PD. Potential for enriching next-generation health-promoting gut bacteria through prebiotics and
other dietary components. Gut Microbes 2020;11:1-20. DOI PubMed PMC
55. Rossi O, Khan MT, Schwarzer M, et al. Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric matrix attenuate
clinical parameters in DSS-induced colitis. PLoS One 2015;10:e0123013. DOI PubMed PMC
56. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut
microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008;105:16731-6. DOI PubMed PMC
57. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS
Microbiol Lett 2009;294:1-8. DOI PubMed
58. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and
extraintestinal diseases. World J Gastroenterol 2011;17:1519-28. DOI PubMed PMC
59. Fitzgerald CB, Shkoporov AN, Sutton TDS, et al. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of
genome plasticity and warrants separation into new species-level taxa. BMC Genomics 2018;19:931. DOI PubMed PMC
60. Martín R, Miquel S, Benevides L, et al. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy
volunteers: a step forward in the use of F. prausnitzii as a next-generation probiotic. Front Microbiol 2017;8:1226. DOI PubMed
PMC
61. Dewulf EM, Cani PD, Claus SP, et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study
with inulin-type fructans in obese women. Gut 2013;62:1112-21. DOI PubMed PMC
62. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of
Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009;101:541-50. DOI PubMed
63. Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in
vitro. FEMS Microbiol Ecol 2014;87:30-40. DOI PubMed
64. Davis LM, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides
results in a highly specific bifidogenic response in humans. PLoS One 2011;6:e25200. DOI PubMed PMC
65. Nyangale EP, Farmer S, Keller D, Chernoff D, Gibson GR. Effect of prebiotics on the fecal microbiota of elderly volunteers after
dietary supplementation of Bacillus coagulans GBI-30, 6086. Anaerobe 2014;30:75-81. DOI PubMed
66. Sijbers AM, Schoemaker RJW, Nauta A, Alkema W. Revealing new leads for the impact of galacto-oligosaccharides on gut
commensals and gut health benefits through text mining. Benef Microbes 2020;11:283-302. DOI PubMed